Sun Pharma to acquire Caraco's remaining stake

23 Feb 2011 Evaluate

Sun Pharmaceutical Industries and its subsidiaries are acquiring the remaining 24.2 per cent stake in US-based Caraco Pharmaceutical Laboratories. Sun Pharma will pay $5.25 per share. This is $0.50 more than the proposed price of $4.75 a share, which Sun Pharma had offered its shareholders in its proposal to delist Caraco Pharma from stock exchange.
 
After acquiring Caraco Pharma in 1997, Sun Pharma has been increasing its stake upon completion of certain agreements between the two. In December, Sun Pharma had offered $4.75 a share to the shareholders.  The move came after the US Food and Drug Administration issued a warning for manufacturing practice violations at Caraco Pharma’s Cranbury facility in New Jersey in September last year. The regulator had withheld approval of pending new drug applications of the company. This was the second regulatory warning for Caraco Pharma.
In June 2009, Caraco’s Michigan facilities in Detroit, Farmington Hills, and Wixom were raided by US marshals and production was stopped for alleged breach of manufacturing regulations.

Sun Pharma Inds. Share Price

1721.45 1.85 (0.11%)
31-Dec-2025 10:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1721.45
Dr. Reddys Lab 1264.70
Cipla 1496.90
Zydus Lifesciences 911.00
Lupin 2087.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×